Login to Your Account

Gossamer takes wing with $100M series A round

By Michael Fitzhugh
Staff Writer

Friday, January 5, 2018

Gossamer Bio Inc., a new company looking to leverage what it called "an asset-rich in-licensing environment," has raised $100 million from Arch Venture Partners and Omega Funds to rev up operations, advance trials for its early and late-stage candidates, and further augment its pipeline.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription